New pharmacologic aspects of beta-diethyl-aminoethyl 2,2-diphenylpentanoate.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004158:Diphenylacetic Acids / Q000494:pharmacology; D066298:In Vitro Techniques; D007583:Jejunum / Q000187:drug effects*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D011335:Proadifen / Q000494:pharmacology*; D051381:Rats; D013053:Spectrophotometry; D013566:Sympathomimetics / Q000494:pharmacology*
D004158:Diphenylacetic Acids; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D013566:Sympathomimetics; D001285:Atropine; D011335:Proadifen